TIS tissue therapies limited

next agm., page-28

  1. 4,014 Posts.
    lightbulb Created with Sketch. 2069
    The way I see it, TIS were offered a deal in March and management rejected it as they felt it was selling themselves short. So, they discussed with the potential partners what they had to do to get a deal on their terms and have set about implementing that plan.

    If they can't get a deal done after the conclusion of the latest round of trials I'm going to start seriously questioning what is going on.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.